跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Prolyl Endopeptidase
首页
药物
Prolyl Endopeptidase
Prolyl Endopeptidase
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
N-(2-(4-CYANOTHIAZOLIDIN-3-YL)-2-OXOETHYL)- QUINOLINE-4-CARBOXAMIDES
EP 4263535 A1
申请人: ASTRAZENECA AB
优先权: 2020
CN
EP
US
WO
9 件公开
N-(2-(3-CYANO-2-AZABICYCLO[3.1.0]HEXAN-2-YL)-2-OXOETHYL)- QUINOLINE-4-CARBOXAMIDES
EP 4543869 A1
申请人: ASTRAZENECA AB
优先权: 2022
CN
EP
US
WO
4 件公开
RADIO-PHARMACEUTICAL COMPLEXES
EP 3468619 A1
申请人: BAYER PHARMA AG
优先权: 2016
EP
US
WO
3 件公开
N-(2-(4-CYANOTHIAZOLIDIN-3-YL)-2-OXOETHYL)-QUINOLINE-4-CARBOXAMIDES
US 20260070899 A1
申请人: ASTRAZENECA AB
优先权: 2022
CN
US
WO
3 件公开
SOLID-STATE FORMS OF N-(2-(4-CYANOTHIAZOLIDIN-3-YL)-2-OXOETHYL)-6-MORPHOLINOQUINOLINE-4-CARBOXAMIDE
US 20250368637 A1
申请人: ASTRAZENECA AB
优先权: 2022
CN
US
3 件公开
Polypeptide with angiotensin converting enzyme inhibition and preparation method and application thereof
CN 119978057 A
申请人: UNIV JIANGNAN
优先权: 2025
CN
3 件公开
Combined use of enzyme inhibitors and pharmaceutical preparations thereof for the treatment and a prophylaxis of arteriosclerosis, for the treatment and prevention of allergic reactions of type I according to the gell and coombs classification and for the treatment and prevention of dermatological diseases associated with fo
US 2004132639 A1
申请人: ANSORGE SIEGFRIED
优先权: 2001
CN
US
2 件公开
Prolyl endopeptidase mediated destruction of T cell epitopes in whole gluten
US 7563864 B2
申请人: CELIAC SPRUE RES FOUNDATION
优先权: 2005
US
2 件公开
Compounds for the treatment of neurological disorders
US 7667044 B2
申请人: PROBIODRUG AG
优先权: 2005
US
2 件公开
Inhibitors of prolyl endopeptidase
US 7592467 B2
申请人: PROBIODRUG AG
优先权: 2006
US
2 件公开
第 1 / 3 页
上一页
下一页
药物
反馈